Randomized placebo-controlled cross-over designs in clinical trials: a gold standard to be reassessed

Author: Leonard Guillaume   Lafrenaye Sylvie   Goffaux Philippe  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.28, Iss.2, 2012-02, pp. : 245-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content